BRAF and cancer: Retrospective analysis of pts treated with cetuximab or panitumumab at an Italian and a Swiss cancer center.Primary or secondary endpoints were not defined.PCR amplification with specific primers followed by automated sequencing by ABI PRISM 3730 was used to identify KRAS and BRAF sequence variants.